Complementary Efficacy of Antrodia cinnamomea Mycelia on Patients with Chronic Hepatitis C Virus Infection: A Randomized Controlled Pilot Clinical Study

Chun-Hung Chiu¹, Chin-Chu Chen^{2, 3}, Hui-Yu Huang², Chang-Cheng Chen³, Ting-Wei Lin³, Charng-Cherng Chyau¹, Ya-ling Chiou^4, and Wang-Sheng Ko^5,

¹Research Institute of Biotechnology, Hungkuang University, Taichung City 43302, Taiwan

²Department of Food Science, Nutrition, and Nutraceutical Biotechnology, Shih Chien University, Taiwan

³Grape King Biotechnology Inc., Zhongli Dist., Taoyuan City, Taiwan

⁴Department of Nutrition, Master Program of Biomedical Nutrition, Hungkuang University, Taichung, Taiwan

⁵Department of Internal Medicine, Kuang-Tien General Hospital, Taichung, Taiwan

Cite this paper:
Chun-Hung Chiu, Chin-Chu Chen, Hui-Yu Huang, Chang-Cheng Chen, Ting-Wei Lin, Charng-Cherng Chyau, Ya-ling Chiou and Wang-Sheng Ko. Complementary Efficacy of Antrodia cinnamomea Mycelia on Patients with Chronic Hepatitis C Virus Infection: A Randomized Controlled Pilot Clinical Study. Journal of Food and Nutrition Research. 2017; 5(7):481-489. doi: 10.12691/jfnr-5-7-5

Abstract

Objectives: Hepatitis C virus (HCV) can cause liver inflammation. The peginterferon and ribavirin (pegRiba) therapy are used but is still unsatisfactory by side effects. Many studies indicated that Antrodia cinnamomea mycelia (ACM) have beneficial effects on liver function. However, the effect of ACM in chronic hepatitis C (CHC) patients remains unclear. Thus, this study aims to investigate the effects of oral supplementation ACM in chronic hepatitis C patients with pegRiba therapy. Design and interventions: Sixty CHC subjects were randomly collected and were randomly assigned to pegRiba group (30 subjects), or combined treatment with oral ACM (4.68 g/day) (pegRiba +ACM, 30 subjects) for 24-48 weeks. Main outcome measures: The blood samples were taken to analysis levels of biochemical data, viral response, heavy metals, immune function, cytokines and antioxidant status. Results: The results of biochemical data, viral response, immune function, inflammatory cytokines and antioxidant status were not significantly different (p<0.05) between the pegRiba and pegRiba +ACM groups. However, the zinc level of the pegRiba +ACM group was increased significantly after the 12^th week compared with baseline (p<0.05). In addition, lower aluminum, mercury and arsenic levels of the pegRiba +ACM group were presented when compared with baseline (p<0.05). Conclusion: This first pilot study of ACM in CHC patients indicates that the complementary effects of ACM did not induce adverse events during therapy. The oral supplementation ACM could reduce levels of heavy metals and lead to increased zinc level. Increased zinc level is negatively correlated with side effects during the therapy in CHC patients.

Keywords:
chronic hepatitis C Antrodia cinnamomea trace elements heavy metals

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2): 47-52.
[2]	Zoulim F, Chevallier M, Maynard M, Trepo C. Clinical consequences of hepatitis C virus infection. Rev Med Virol. 2003; 13(1): 57-68.
[3]	Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med. 2004; 350(11): 1118-1129.
[4]	Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002; 36(5 Suppl 1): S35-46.
[5]	Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol. 2002; 97(10): 2634-2639.
[6]	Barnes E, Lauer G, Walker B, Klenerman P. T cell failure in hepatitis C virus infection. Viral Immunol. 2002; 15(2): 285-293.
[7]	Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005; 5(3): 215-229.
[8]	Rico MA, Quiroga JA, Subira D, et al. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J Hepatol. 2002; 36(3): 408-416.
[9]	Penna A, Missale G, Lamonaca V, et al. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology. 2002; 35(5): 1225-1236.
[10]	Koziel MJ, Dudley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 1992; 149(10): 3339-3344.
[11]	Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002; 347(13): 975-982.
[12]	Park DK, Lim YH, Park HJ. Antrodia camphorata grown on germinated brown rice inhibits HT-29 human colon carcinoma proliferation through inducing G0/G1 phase arrest and apoptosis by targeting the beta-catenin signaling. J Med Food. 2013; 16(8): 681-691.
[13]	Chen CC, Liu YW, Ker YB, et al. Chemical characterization and anti-inflammatory effect of polysaccharides fractionated from submerge-cultured Antrodia camphorata mycelia. J Agric Food Chem. 2007; 55(13): 5007-5012.
[14]	Song TY, Yen GC. Protective effects of fermented filtrate from Antrodia camphorata in submerged culture against CCl4-induced hepatic toxicity in rats. J Agric Food Chem. 2003; 51(6): 1571-1577.
[15]	Wu YY, Chen CC, Chyau CC, Chung SY, Liu YW. Modulation of inflammation-related genes of polysaccharides fractionated from mycelia of medicinal basidiomycete Antrodia camphorata. Acta Pharmacol Sin. 2007; 28(2): 258-267.
[16]	Song TY, Yen GC. Antioxidant properties of Antrodia camphorata in submerged culture. J Agric Food Chem. 2002; 50(11): 3322-3327.
[17]	Mau JL, Lin HC, Chen CC. Antioxidant properties of several medicinal mushrooms. J Agric Food Chem. 2002; 50(21): 6072-6077.
[18]	Cheng PC, Hsu CY, Chen CC, Lee KM. In vivo immunomodulatory effects of Antrodia camphorata polysaccharides in a T1/T2 doubly transgenic mouse model for inhibiting infection of Schistosoma mansoni. Toxicol Appl Pharmacol. 2008; 227(2): 291-298.
[19]	Ker YB, Peng CC, Chang WL, Chyau CC, Peng RY. Hepatoprotective bioactivity of the glycoprotein, antrodan, isolated from Antrodia cinnamomea mycelia. PLoS One. 2014; 9(4): e93191.
[20]	Mathon C, Duret M, Kohler M, Edder P, Bieri S, Christen P. Multi-targeted screening of botanicals in food supplements by liquid chromatography with tandem mass spectrometry. Food Chem. 2013; 138(1): 709-717.
[21]	Lee IH, Huang RL, Chen CT, Chen HC, Hsu WC, Lu MK. Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiol Lett. 2002; 209(1): 63-67.
[22]	Duffy DM, Lindheim SR, Vijod MA, Chang L, Nakamura RM, Lobo RA. Low-dose growth hormone-releasing factor may enhance folliculogenesis in regularly menstruating women: a preliminary study. Fertil Steril. 1995; 63(4): 756-760.
[23]	Hseu YC, Chen SC, Tsai PC, et al. Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food Chem Toxicol. 2007; 45(7): 1107-1115.
[24]	Liu DZ, Liang YC, Lin SY, et al. Antihypertensive activities of a solid-state culture of Taiwanofungus camphoratus (Chang-chih) in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 2007; 71(1): 23-30.
[25]	Yang HL, Chen CS, Chang WH, et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett. 2006; 231(2): 215-227.
[26]	Chen TI, Chen CC, Lin TW, Tsai YT, Nam MK. A 90-day subchronic toxicological assessment of Antrodia cinnamomea in Sprague-Dawley rats. Food Chem Toxicol. 2011; 49(2): 429-433.
[27]	Sturgill MG, Lambert GH. Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin Chem. 1997; 43(8 Pt 2): 1512-1526.
[28]	Huang TH, Chiu YH, Chan YL, et al. Antrodia cinnamomea alleviates cisplatin-induced hepatotoxicity and enhances chemo-sensitivity of line-1 lung carcinoma xenografted in BALB/cByJ mice. Oncotarget. 2015; 6(28): 25741-25754.
[29]	Loguercio C, De Girolamo V, Federico A, et al. Trace elements and chronic liver diseases. J Trace Elem Med Biol. 1997; 11(3): 158-161.
[30]	Halifeoglu I, Gur B, Aydin S, Ozturk A. Plasma trace elements, vitamin B12, folate, and homocysteine levels in cirrhotic patients compared to healthy controls. Biochemistry (Mosc). 2004; 69(6): 693-696.
[31]	Poo JL, Rosas-Romero R, Montemayor AC, Isoard F, Uribe M. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study. J Gastroenterol. 2003; 38(1): 45-51.
[32]	Loguercio C, De Girolamo V, Federico A, et al. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol Trace Elem Res. 2001; 81(3): 245-254.
[33]	Nagamine T, Takagi H, Takayama H, et al. Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b. Biol Trace Elem Res. 2000; 75(1-3): 53-63.
[34]	Ko WS, Guo CH, Hsu GS, Chiou YL, Yeh MS, Yaun SR. The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. Clin Biochem. 2005; 38(7): 614-620.
[35]	Guo CH, Chen PC, Lin KP, Shih MY, Ko WS. Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects. Environ Toxicol Pharmacol. 2012; 33(2): 288-296.
[36]	Sheehan MC, Burke TA, Breysse PN, Navas-Acien A, McGready J, Fox MA. Association of markers of chronic viral hepatitis and blood mercury levels in US reproductive-age women from NHANES 2001-2008: a cross-sectional study. Environ Health. 2012; 11: 62.
[37]	Murakami K, Yoshino M. Aluminum decreases the glutathione regeneration by the inhibition of NADP-isocitrate dehydrogenase in mitochondria. J Cell Biochem. 2004; 93(6): 1267-1271.
[38]	Liu T, He W, Yan C, Qi Y, Zhang Y. Roles of reactive oxygen species and mitochondria in cadmium-induced injury of liver cells. Toxicol Ind Health. 2011; 27(3): 249-256.
[39]	Afonne OJ, Orisakwe OE, Ndubuka GI, Akumka DD, Ilondu N. Zinc protection of mercury-induced hepatic toxicity in mice. Biol Pharm Bull. 2000; 23(3): 305-308.
[40]	Wang, K. L. The effect of mycelia of Antrodia cinnamomea on mercury- induced damage of rat’s liver and kidney. Master, Hungkuang University, Taichung. 1998
[41]	Chen CC, Li IC, Lin TW, Cheng H L, Lin WH, & Shene YC. Efficacy and safety of oral Antrodia cinnamomea mycelium in mildly hypertensive adults: A randomized controlled pilot clinical study. Eur J Integr Med. 2016: 8: 654-660.
[42]	Chiu CH, Peng CC, Ke YB, Chen CC, Lee A, Chang WL, Chyau CC, Peng RY. Physicochemical Characteristics and Anti-Inflammatory Activities of Antrodan, a Novel Glycoprotein Isolated from Antrodia cinnamomea Mycelia. Molecules 2014:19: 22-40.
[43]	Maggini S, Wintergerst, ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007: 98: S29-S35.